California 2019-2020 Regular Session

California Senate Bill SB1084

Introduced
2/19/20  
Refer
3/5/20  
Refer
3/5/20  

Caption

Pharmacy: dispensing: controlled substances.

Impact

This bill fundamentally alters the processes surrounding the dispensation of controlled substances in California's pharmacies. By requiring medications to be secured in lockable vials, the state seeks to mitigate risks associated with unauthorized access and diversion of prescription drugs. Additionally, the bill establishes that manufacturers are responsible for reimbursing pharmacies for the costs associated with these lockable vials. This could lead to improved adherence to safety protocols by pharmacies and foster a culture of responsible medication management among patients.

Summary

Senate Bill 1084, known as the California Safe Dispensing Act, establishes new regulations for the dispensing of controlled substances in solid oral dosage form, particularly for those classified under Schedule II and Schedule IIN of the federal Controlled Substances Act. Effective June 30, 2021, pharmacies will be required to dispense these substances in lockable vials, which are defined as containers that feature a secure locking mechanism accessible only by the patient or their designated representative. The legislation also mandates the provision of an educational pamphlet on controlled substance information, aiming to enhance patient awareness regarding the potential for abuse and diversion of these medications.

Sentiment

The reception of SB 1084 seems to be mixed, with proponents emphasizing the bill's potential to enhance drug safety and protect communities from the misuse of powerful medications. However, some stakeholders express concerns regarding the logistical implications for pharmacies and the financial burden placed on manufacturers for compliance. The focus on patient education is viewed positively among health advocates, who see it as a necessary step toward public health improvement.

Contention

Notable points of contention include the imposition of civil penalties against manufacturers who fail to reimburse pharmacies for the costs associated with lockable vials, as well as concerns over the practicality of requiring patients to access medications secured in these vials. Some critics argue that while the intentions behind the bill are commendable, the implementation could create obstacles for patients, particularly those with disabilities or in inpatient care settings, who may struggle to reach or operate these secure containers.

Companion Bills

No companion bills found.

Similar Bills

CA AB1430

Pharmacy: dispensing: controlled substances.

CA AB2265

Pharmacy: dispensing controlled substances: lockable vials.

CA AB401

Pharmacy: remote dispensing site pharmacy: telepharmacy: shared clinic office space.

CA AB1286

Pharmacy.

CA AB602

Pharmacy: nonprescription diabetes test devices.